These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3501723)

  • 1. Study on the possible interaction between tenoxicam and furosemide.
    Hartmann D; Kleinbloesem CH; Lücker PW; Vetter G
    Arzneimittelforschung; 1987 Sep; 37(9):1072-6. PubMed ID: 3501723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the possible interaction between tenoxicam and atenolol in hypertensive patients.
    Hartmann D; Stief G; Lingenfelder M; Güzelhan C; Horsch AK
    Arzneimittelforschung; 1995 Apr; 45(4):494-8. PubMed ID: 7779149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tenoxicam on renal function and the disposition of inulin and p-aminohippurate in healthy volunteers and patients with chronic renal failure.
    Freestone S; McAuslane JA; Prescott LF
    Br J Clin Pharmacol; 1991 Oct; 32(4):495-500. PubMed ID: 1958445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tenoxicam and renal function. Short-term and long-term prospective studies].
    Giovannoni JL; Ott H; de Torrenté A
    Schweiz Med Wochenschr; 1990 May; 120(21):793-7. PubMed ID: 2349462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenoxicam i.v. for major gynaecological surgery--effects on renal function.
    Jones RD; Endre Z; Miles W; Prankerd R; Chilvers M; Willgoss D
    Anaesth Intensive Care; 2000 Oct; 28(5):501-9. PubMed ID: 11094664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man.
    Brater DC; Beck JM; Adams BV; Campbell WB
    Eur J Pharmacol; 1980 Jul; 65(2-3):213-9. PubMed ID: 7398787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of mofebutazone with furosemide.
    Matthei U; Grabensee B; Loew D
    Curr Med Res Opin; 1987; 10(9):638-44. PubMed ID: 3481307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.
    Nilsen OG; Aasarød K; Widerøe TE; Guentert TW
    Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of furosemide on urinary excretion of prostaglandin E2 and F2 alpha in rabbits.
    Oliw E; Anggård E
    Acta Physiol Scand; 1979 Mar; 105(3):367-73. PubMed ID: 443065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2.
    Katayama S; Attallah AA; Stahl RA; Bloch DL; Lee JB
    Am J Physiol; 1984 Oct; 247(4 Pt 2):F555-61. PubMed ID: 6594069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of renal prostaglandins by pressor hormones in man: comparison of prostaglandin E2 and prostacyclin (6 keto prostaglandin F1 alpha).
    Nadler J; Zipser RD; Coleman R; Horton R
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1260-5. PubMed ID: 6341391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of propranolol treatment on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension.
    Rathaus M; Bernheim J
    Isr J Med Sci; 1982 Feb; 18(2):231-4. PubMed ID: 6950926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronopharmacological study of furosemide in rats.
    Fujimura A; Ebihara A
    Life Sci; 1986 Mar; 38(13):1215-20. PubMed ID: 3457231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.
    Haas M; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
    Clin Sci (Lond); 1998 Nov; 95(5):603-9. PubMed ID: 9791047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenoxicam and renal function.
    Heintz RC
    Drug Saf; 1995 Feb; 12(2):110-9. PubMed ID: 7766336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney.
    Pelligand L; Suemanotham N; King JN; Seewald W; Syme H; Smith K; Lees P; Elliott J
    BMC Vet Res; 2015 Dec; 11():296. PubMed ID: 26634699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elimination profiles of tenoxicam and hydroxytenoxicam in equine urine and serum after a 200-mg oral dose.
    Marland A; Sarkar P; Leavitt R
    J Anal Toxicol; 1999; 23(4):237-41. PubMed ID: 10445485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers.
    Day RO; Geisslinger G; Paull P; Williams KM
    Int J Clin Pharmacol Ther; 1995 May; 33(5):308-10. PubMed ID: 7655772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man.
    Giannessi D; Lazzerini G; Filipponi P; Mannarelli C; Vaiani G; Grossi E; De Caterina R
    Pharmacol Res; 1993; 28(3):229-41. PubMed ID: 8108313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.